Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antibody-drug conjugates in breast cancer: overcoming resistance and boosting immune response. | J Clin Invest | 2023 | 37712425 | PubTator, text mining | PubMed |
| Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiency. | Neurooncol Adv | 2023 | 37706203 | PubTator, text mining | PubMed |
| Random pruning: channel sparsity by expectation scaling factor. | PeerJ Comput Sci | 2023 | 37705629 | PubTator, text mining | PubMed |
| Neddylation inhibitor MLN4924 sensitizes head and neck squamous carcinoma cells to (S)-10-hydroxycamptothecin. | Eur J Med Res | 2023 | 37689760 | PubTator, text mining | PubMed |
| Discovery of VIP236, an αvβ3-Targeted Small-Molecule-Drug Conjugate with Neutrophil Elastase-Mediated Activation of 7-Ethyl Camptothecin Payload for Treatment of Solid Tumors. | Cancers (Basel) | 2023 | 37686656 | PubTator, text mining | PubMed |
| Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA). | Cancer Cell Int | 2023 | 37679807 | PubTator, text mining | PubMed |
| Exploring a new mechanism between lactate and VSMC calcification: PARP1/POLG/UCP2 signaling pathway and imbalance of mitochondrial homeostasis. | Cell Death Dis | 2023 | 37679327 | PubTator, text mining | PubMed |
| Halimanes and cancer: ent-halimic acid as a starting material for the synthesis of antitumor drugs. | Front Chem | 2023 | 37674527 | PubTator, text mining | PubMed |
| Real-time imaging of drug-induced trapping of cellular topoisomerases and poly(ADP-ribose) polymerase 1 at the single-molecule level. | Nucleic Acids Res | 2023 | 37670571 | PubTator, text mining | PubMed |
| A Cell Surface-Binding Antibody Atlas Nominates a MUC18-Directed Antibody-Drug Conjugate for Targeting Melanoma. | Cancer Res | 2023 | 37668527 | PubTator, text mining | PubMed |
| The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer. | Nat Commun | 2023 | 37666855 | PubTator, text mining | PubMed |
| Predicting Response to Antibody Drug Conjugates: A Focus on Antigens' Targetability. | Oncologist | 2023 | 37665782 | PubTator, text mining | PubMed |
| Prognosis signature for predicting the survival and immunotherapy response in esophageal carcinoma based on cellular senescence-related genes. | Front Oncol | 2023 | 37664030 | PubTator, text mining | PubMed |
| Drug conjugates for targeting regulatory T cells in the tumor microenvironment: guided missiles for cancer treatment. | Exp Mol Med | 2023 | 37653036 | PubTator, text mining | PubMed |
| diseaseGPS: auxiliary diagnostic system for genetic disorders based on genotype and phenotype. | Bioinformatics | 2023 | 37647638 | PubTator, text mining | PubMed |
| Identification of immune infiltration-related biomarkers in carotid atherosclerotic plaques. | Sci Rep | 2023 | 37644056 | PubTator, text mining | PubMed |
| A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma. | Front Oncol | 2023 | 37637064 | PubTator, text mining | PubMed |
| Plant disease prescription recommendation based on electronic medical records and sentence embedding retrieval. | Plant Methods | 2023 | 37633904 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates: Ushering in a New Era of Cancer Therapy. | Pharmaceutics | 2023 | 37631232 | PubTator, text mining | PubMed |
| Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells. | Cells | 2023 | 37626856 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=25